Intrahost modeling of artemisinin resistance in Plasmodium falciparum
about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumSpread of artemisinin resistance in Plasmodium falciparum malariaArtemisinin-resistant malaria: research challenges, opportunities, and public health implicationsIn vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosaEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyGlobal phenotypic screening for antimalarialsPharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationMaking the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugsMathematical Modelling to Guide Drug Development for Malaria EliminationPlasmodium falciparum: multifaceted resistance to artemisininsMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studyImproving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsRapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasitesTargeting the cell stress response of Plasmodium falciparum to overcome artemisinin resistanceOptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Inhibition by stabilization: targeting the Plasmodium falciparum aldolase-TRAP complexPopulation pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Laboratory detection of artemisinin-resistant Plasmodium falciparumPyronaridine: a new 'old' drug on the verge of entering the antimalarial armamentarium.Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription.Altered temporal response of malaria parasites determines differential sensitivity to artemisininEmerging artemisinin resistance in the border areas of Thailand.Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.Artemisinin resistance--modelling the potential human and economic costs.Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failureModelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesDrug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.Phenotypic changes in artemisinin-resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition.A major genome region underlying artemisinin resistance in malariaAltering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.Counter perspective: artemisinin resistance: facts, fears, and fables
P2860
Q21032477-F2E64C1C-3971-4EF7-801A-11CA8528E567Q21032481-2A80C50C-41B4-487D-8387-7594280CB407Q21032532-A3B5F265-BEF1-47DD-B79A-A11D81D1615BQ21034096-E88145F6-6415-46D5-96A9-948F12AAAA51Q24598695-6C56DA92-1CE0-4EB8-859B-D29776220995Q26824875-728FC522-96FE-47FF-BF42-751856336D20Q26830528-D977EBCB-E307-40F9-9163-863BC164C80FQ27025529-605D205B-0F08-42C3-8B16-47F365A5E624Q28067367-295BAB33-84ED-4A2D-A05B-53F483A4630AQ28069384-A728C1C4-3F77-4E20-B1B3-092BB1026C83Q28487636-D2E0F018-DFA5-4198-BE4D-B1BD9719C279Q28534701-C7BB32E2-AB65-4FA1-A415-D7907823E33BQ28538245-8EAFA23B-A752-4E3E-8A03-85497B893204Q28546636-61970CEB-F7FE-4879-849D-0F7C3F6CE51DQ28831110-88C7A09E-D8C3-4FFF-9B24-9756DC01FD02Q30240158-0AFAEB78-18E9-4DA8-A8B5-3C7842AD9345Q30619647-A6A4BBDF-2EE3-496C-A000-A97F6D13997CQ30662033-48811BF7-98F4-4C17-ABAE-9CD2C8E2A1CDQ30867699-AC72EAF7-903C-4492-A1E0-8B6ADB232D56Q33655603-5D1D9203-A904-48C9-84A1-2DCADD24FF26Q33678483-88763282-592C-48A5-B101-C8485A18FECDQ33798139-D6C6B7B7-5345-4C1B-B6AB-E2410A66E9ADQ33876781-410FC61D-1686-48D0-BBF4-185C56A67ED2Q33979085-7476C607-9777-4F34-8CCA-5F7522D14259Q34329125-057A82D4-89F8-46EF-9981-E78A9A081ED6Q34343530-098D0549-3722-411C-AC49-33DC0ECB7134Q34453540-E6203EB3-4130-40D3-BA4A-32EBFBAB71A4Q34623414-DD03C844-51F6-4E7C-8EB6-E753741035DCQ34698875-6BCA3B55-6E0E-4760-B60D-292DF60D3AB4Q34953705-5D7D95FF-09D3-4904-8877-4099C7D28AD2Q35146682-98B08AFC-C8A8-4FB3-8947-D6C82B5D28D6Q35217991-D86E5B80-ED93-46F1-95DE-859234AC896FQ35666398-9368BBA6-8F2D-4502-BFD4-B1B3A82AD776Q35969854-075F9673-F96F-4453-AB10-7E1F75CB313AQ36075783-9DE511EC-08BC-47D6-B4B7-128B36EF6268Q36076111-A52363A1-715A-48AE-90D7-A99845A7234DQ36108352-972040B8-25D5-4CAF-B3A1-33C66CEB8420Q36277347-AC9FCE00-A2EA-4CD3-8538-160A66E213DDQ36364184-3794645F-39CF-4568-BC13-BF8D55414C2BQ36450590-136CFBF5-8C85-484E-9494-5417D5FD9624
P2860
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@ast
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@en
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@nl
type
label
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@ast
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@en
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@nl
prefLabel
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@ast
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@en
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@nl
P2093
P2860
P50
P356
P1476
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
@en
P2093
Duong Socheat
Lisa J White
Niklas Lindegårdh
P2860
P304
P356
10.1073/PNAS.1006113108
P407
P50
P577
2010-12-20T00:00:00Z